Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders.

adversarial autoencoders conditional generation deep learning drug discovery gene expression generative models representation learning

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 11 11 2019
accepted: 25 02 2020
entrez: 5 5 2020
pubmed: 5 5 2020
medline: 5 5 2020
Statut: epublish

Résumé

Gene expression profiles are useful for assessing the efficacy and side effects of drugs. In this paper, we propose a new generative model that infers drug molecules that could induce a desired change in gene expression. Our model-the Bidirectional Adversarial Autoencoder-explicitly separates cellular processes captured in gene expression changes into two feature sets: those

Identifiants

pubmed: 32362822
doi: 10.3389/fphar.2020.00269
pmc: PMC7182000
doi:

Types de publication

Journal Article

Langues

eng

Pagination

269

Informations de copyright

Copyright © 2020 Shayakhmetov, Kuznetsov, Zhebrak, Kadurin, Nikolenko, Aliper and Polykovskiy.

Références

Mol Pharm. 2018 Oct 1;15(10):4398-4405
pubmed: 30180591
Sci Rep. 2018 Oct 15;8(1):15264
pubmed: 30323214
J R Soc Interface. 2018 Apr;15(141):
pubmed: 29618526
Bioinformatics. 2018 Sep 1;34(17):3035-3037
pubmed: 29659719
Science. 2018 Jul 27;361(6400):360-365
pubmed: 30049875
PLoS Comput Biol. 2017 Feb 24;13(2):e1005403
pubmed: 28234893
Mol Pharm. 2018 Oct 1;15(10):4386-4397
pubmed: 29569445
Oncotarget. 2017 Feb 14;8(7):10883-10890
pubmed: 28029644
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954
pubmed: 27899562
J Chem Inf Model. 2013 Jul 22;53(7):1563-75
pubmed: 23795551
Sci Rep. 2019 Jan 15;9(1):142
pubmed: 30644411
J Chem Inf Model. 2015 Feb 23;55(2):263-74
pubmed: 25635324
Front Genet. 2018 Jul 12;9:242
pubmed: 30050560
Bioinformatics. 2016 Jun 15;32(12):1832-9
pubmed: 26873929
Mol Inform. 2016 Jan;35(1):3-14
pubmed: 27491648
J Chem Inf Model. 2018 Jun 25;58(6):1194-1204
pubmed: 29762023
Mol Pharm. 2018 Oct 1;15(10):4311-4313
pubmed: 30269508
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W449-60
pubmed: 24906883
Oncotarget. 2017 Dec 28;9(8):7796-7811
pubmed: 29487692
Nat Commun. 2016 Nov 16;7:13427
pubmed: 27848968
Clin Cancer Res. 2018 Mar 15;24(6):1248-1259
pubmed: 28982688
Mol Pharm. 2016 May 2;13(5):1445-54
pubmed: 27007977
Mol Pharm. 2016 Jul 5;13(7):2524-30
pubmed: 27200455
Mol Pharm. 2017 Sep 5;14(9):3098-3104
pubmed: 28703000
ACS Cent Sci. 2018 Jan 24;4(1):120-131
pubmed: 29392184
J Gerontol A Biol Sci Med Sci. 2018 Oct 8;73(11):1482-1490
pubmed: 29340580
ACS Cent Sci. 2018 Feb 28;4(2):268-276
pubmed: 29532027
Aging (Albany NY). 2017 Nov 15;9(11):2245-2268
pubmed: 29165314
Mol Pharm. 2018 Oct 1;15(10):4378-4385
pubmed: 29473756
Aging (Albany NY). 2016 May;8(5):1021-33
pubmed: 27191382
Nat Biotechnol. 2019 Sep;37(9):1038-1040
pubmed: 31477924

Auteurs

Rim Shayakhmetov (R)

Insilico Medicine, Hong Kong, Hong Kong.

Maksim Kuznetsov (M)

Insilico Medicine, Hong Kong, Hong Kong.

Alexander Zhebrak (A)

Insilico Medicine, Hong Kong, Hong Kong.

Artur Kadurin (A)

Insilico Medicine, Hong Kong, Hong Kong.

Sergey Nikolenko (S)

Insilico Medicine, Hong Kong, Hong Kong.
Neuromation OU, Tallinn, Estonia.

Alexander Aliper (A)

Insilico Medicine, Hong Kong, Hong Kong.

Daniil Polykovskiy (D)

Insilico Medicine, Hong Kong, Hong Kong.

Classifications MeSH